UiPath Inc. (NASDAQ:PATH) Receives Average Recommendation of “Hold” from Analysts

UiPath Inc. (NASDAQ:PATHGet Rating) has been given an average rating of “Hold” by the twenty-six brokerages that are currently covering the stock, MarketBeat reports. Three equities research analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and twelve have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $48.07.

A number of brokerages have recently weighed in on PATH. Wells Fargo & Company dropped their price objective on shares of UiPath from $45.00 to $35.00 and set an “overweight” rating on the stock in a report on Thursday, March 31st. Truist Financial decreased their target price on shares of UiPath from $75.00 to $55.00 and set a “buy” rating for the company in a research report on Thursday, March 31st. Barclays decreased their target price on shares of UiPath from $61.00 to $57.00 in a research report on Wednesday, January 12th. Zacks Investment Research downgraded shares of UiPath from a “hold” rating to a “strong sell” rating in a research report on Thursday, April 7th. Finally, Needham & Company LLC decreased their target price on shares of UiPath from $85.00 to $40.00 and set a “buy” rating for the company in a research report on Thursday, March 31st.

In related news, Director Kimberly Hammonds sold 2,521 shares of the company’s stock in a transaction dated Friday, March 18th. The shares were sold at an average price of $28.19, for a total transaction of $71,066.99. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Rich Wong sold 75,000 shares of the company’s stock in a transaction dated Friday, February 18th. The stock was sold at an average price of $37.81, for a total transaction of $2,835,750.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 152,521 shares of company stock valued at $5,729,067. Insiders own 31.88% of the company’s stock.

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Evoke Wealth LLC grew its stake in UiPath by 19.0% during the 3rd quarter. Evoke Wealth LLC now owns 1,706 shares of the healthcare company’s stock valued at $89,000 after acquiring an additional 272 shares in the last quarter. Benjamin Edwards Inc. grew its stake in UiPath by 65.4% during the 4th quarter. Benjamin Edwards Inc. now owns 708 shares of the healthcare company’s stock valued at $31,000 after acquiring an additional 280 shares in the last quarter. Harbor Investment Advisory LLC grew its stake in UiPath by 56.5% during the 4th quarter. Harbor Investment Advisory LLC now owns 1,194 shares of the healthcare company’s stock valued at $51,000 after acquiring an additional 431 shares in the last quarter. Neuberger Berman Group LLC grew its stake in UiPath by 4.4% during the 3rd quarter. Neuberger Berman Group LLC now owns 11,861 shares of the healthcare company’s stock valued at $624,000 after acquiring an additional 501 shares in the last quarter. Finally, Evolution Wealth Advisors LLC purchased a new stake in UiPath during the 3rd quarter valued at about $28,000. 52.19% of the stock is owned by institutional investors.

Shares of PATH traded down $1.15 during trading hours on Tuesday, reaching $14.71. 293,369 shares of the company traded hands, compared to its average volume of 6,423,057. The stock has a market capitalization of $7.97 billion and a P/E ratio of -9.04. UiPath has a 12-month low of $15.74 and a 12-month high of $90.00. The business has a fifty day moving average price of $23.58 and a 200-day moving average price of $36.28.

UiPath (NASDAQ:PATHGet Rating) last announced its quarterly earnings data on Wednesday, March 30th. The healthcare company reported $0.05 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.02. The firm had revenue of $289.70 million for the quarter, compared to analyst estimates of $283.25 million. UiPath had a negative net margin of 58.91% and a negative return on equity of 21.20%. The firm’s revenue for the quarter was up 39.3% compared to the same quarter last year. On average, analysts anticipate that UiPath will post -0.46 EPS for the current fiscal year.

About UiPath (Get Rating)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Read More

Analyst Recommendations for UiPath (NASDAQ:PATH)

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.